ZNF417
gene geneOn this page
Also known as MGC34079
Summary
ZNF417 (zinc finger protein 417, HGNC:20646) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 417 (Q8TAU3). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 147687 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 107 total
- MANE Select transcript:
NM_152475
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20646 |
| Approved symbol | ZNF417 |
| Name | zinc finger protein 417 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC34079 |
| Ensembl gene | ENSG00000173480 |
| Ensembl biotype | protein_coding |
| OMIM | 621276 |
| Entrez | 147687 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 protein_coding
ENST00000312026, ENST00000594396, ENST00000595559, ENST00000597515, ENST00000598526, ENST00000598629, ENST00000599251
RefSeq mRNA: 2 — MANE Select: NM_152475
NM_001297734, NM_152475
CCDS: CCDS12965, CCDS74469
Canonical transcript exons
ENST00000312026 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001431532 | 57905774 | 57910114 |
| ENSE00003214830 | 57916379 | 57916592 |
| ENSE00003654141 | 57912060 | 57912189 |
Expression profiles
Bgee: expression breadth ubiquitous, 174 present calls, max score 90.81.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.7058 / max 55.9687, expressed in 1688 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182919 | 6.7058 | 1688 |
Top tissues by expression
232 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adenohypophysis | UBERON:0002196 | 90.81 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 89.82 | gold quality |
| cerebellar cortex | UBERON:0002129 | 89.53 | gold quality |
| cortical plate | UBERON:0005343 | 89.44 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 89.18 | gold quality |
| right uterine tube | UBERON:0001302 | 87.71 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 87.30 | gold quality |
| pituitary gland | UBERON:0000007 | 87.22 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 86.97 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 86.75 | gold quality |
| cerebellum | UBERON:0002037 | 86.09 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 86.03 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 86.02 | gold quality |
| ganglionic eminence | UBERON:0004023 | 85.98 | gold quality |
| right frontal lobe | UBERON:0002810 | 85.37 | gold quality |
| thyroid gland | UBERON:0002046 | 85.33 | gold quality |
| apex of heart | UBERON:0002098 | 85.30 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 85.11 | gold quality |
| spleen | UBERON:0002106 | 85.07 | gold quality |
| minor salivary gland | UBERON:0001830 | 84.94 | gold quality |
| right lobe of liver | UBERON:0001114 | 84.76 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 84.64 | gold quality |
| gall bladder | UBERON:0002110 | 84.62 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.19 | gold quality |
| hypothalamus | UBERON:0001898 | 83.98 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.96 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 83.69 | gold quality |
| lower esophagus | UBERON:0013473 | 83.68 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 83.61 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 83.56 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.29 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| CDKN2A |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1727.1 | ZNF417 | Factors with multiple dispersed zinc fingers |
| MA1727.2 | ZNF417 | Factors with multiple dispersed zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:32923624
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
97 targeting ZNF417, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-6772-5P | 99.94 | 67.01 | 577 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-548AG | 99.77 | 69.25 | 1492 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
Cross-species orthologs
0 orthologs
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)
Protein
Protein identifiers
Zinc finger protein 417 — Q8TAU3 (reviewed: Q8TAU3)
All UniProt accessions (7): Q8TAU3, M0QXH9, M0R0M6, M0R0V5, M0R178, M0R230, M0R267
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TAU3-1 | 1 | yes |
| Q8TAU3-2 | 2 |
RefSeq proteins (2): NP_001284663, NP_689688* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050758 | Znf_C2H2-type | Family |
Pfam: PF00096, PF01352
UniProt features (21 total): zinc finger region 13, sequence conflict 2, chain 1, domain 1, region of interest 1, compositionally biased region 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TAU3-F1 | 64.65 | 0.21 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 37 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES, DIDO1_TARGET_GENES, PRKDC_TARGET_GENES, SETD7_TARGET_GENES, TAFAZZIN_TARGET_GENES, ZNF197_TARGET_GENES, ZNF350_TARGET_GENES, ZNF362_TARGET_GENES, ZNF597_TARGET_GENES, MIR340_5P, LET_7C_3P
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of DNA-templated transcription (GO:0045892), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
584 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF417 | OR8D2 | Q9GZM6 | 624 |
| ZNF417 | GRIP2 | Q9C0E4 | 479 |
| ZNF417 | GLRA2 | P23416 | 448 |
| ZNF417 | OR51M1 | Q9H341 | 447 |
| ZNF417 | CCDC74A | Q96AQ1 | 444 |
| ZNF417 | OR1C1 | Q15619 | 390 |
| ZNF417 | PHOSPHO2 | Q8TCD6 | 375 |
| ZNF417 | G3V325 | G3V325 | 371 |
| ZNF417 | CLHC1 | Q8NHS4 | 370 |
| ZNF417 | LRRC66 | Q68CR7 | 369 |
| ZNF417 | OR2T35 | Q8NGX2 | 359 |
| ZNF417 | KIAA1328 | Q86T90 | 350 |
| ZNF417 | FABP6 | P51161 | 348 |
| ZNF417 | AADAT | Q8N5Z0 | 348 |
| ZNF417 | VN1R1 | Q9GZP7 | 348 |
IntAct
637 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF417 | TRIM27 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF417 | MDFI | psi-mi:“MI:0915”(physical association) | 0.780 |
| MDFI | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.780 |
| TNS2 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FSD2 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| STX11 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT38 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP5-9 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP10-7 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP10-8 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| GOLGA2 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF417 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.720 |
| HMBOX1 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF417 | ADAMTSL4 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CEP70 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM41 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZBTB8A | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KXD1 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| LZTS2 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF417 | TRIM54 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF417 | MID2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF417 | FSD2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF417 | KRTAP5-9 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF417 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (220): ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid)
ESM2 similar proteins: A0JNB1, A1YF12, A1YG88, A2T759, A3KN32, B2RUI1, O43296, O75123, P10072, P17020, P17097, P51814, P52736, P52740, Q07230, Q08ER8, Q13398, Q14590, Q32KN0, Q3KQV3, Q3MIS6, Q4V8A8, Q5CZA5, Q5RBQ3, Q5RBX0, Q5RCD9, Q5RCX4, Q6GQR8, Q6NX45, Q6P9A3, Q6PK81, Q7TSH9, Q7TSI0, Q7Z7L9, Q86UD4, Q8BFS8, Q8BLB0, Q8IVP9, Q8IZ26, Q8N9F8
Diamond homologs: A2RRD8, A6NFI3, A6NM28, A8MUZ8, A8MWA4, B2RUI1, B4DU55, E9Q8G5, O43296, O43361, O75467, O75820, P0CH99, P0CI00, P10078, P16373, P16374, P17021, P17023, P17032, P17097, P17098, P21506, P51786, P52740, Q06732, Q08ER8, Q13106, Q13360, Q13398, Q14592, Q147U1, Q32M78, Q3KQV3, Q3MIS6, Q3SY52, Q571J5, Q5CZA5, Q5HY98, Q5R7I8
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 66 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 9 | 14.3× | 1e-06 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
107 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 89 |
| Likely benign | 10 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1052 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57916377:A:AT | donor_loss | 1.0000 |
| 19:57916377:AC:A | donor_loss | 1.0000 |
| 19:57916378:C:CT | donor_loss | 1.0000 |
| 19:57916378:CC:C | donor_loss | 1.0000 |
| 19:57915568:A:AC | donor_gain | 0.9700 |
| 19:57915569:C:CC | donor_gain | 0.9700 |
| 19:57916377:A:AC | donor_gain | 0.9500 |
| 19:57916378:C:CC | donor_gain | 0.9500 |
| 19:57910112:AACCT:A | acceptor_loss | 0.9400 |
| 19:57910113:ACCTG:A | acceptor_loss | 0.9400 |
| 19:57910115:C:CA | acceptor_loss | 0.9400 |
| 19:57910116:T:A | acceptor_loss | 0.9400 |
| 19:57914990:C:A | acceptor_gain | 0.9400 |
| 19:57910111:CAAC:C | acceptor_gain | 0.9300 |
| 19:57915569:CTGA:C | donor_gain | 0.9300 |
| 19:57912052:CAACT:C | donor_loss | 0.9100 |
| 19:57912053:AACTT:A | donor_loss | 0.9100 |
| 19:57912054:ACTTA:A | donor_loss | 0.9100 |
| 19:57912055:CTTAC:C | donor_loss | 0.9100 |
| 19:57912056:TT:T | donor_loss | 0.9100 |
| 19:57912056:TTA:T | donor_loss | 0.9100 |
| 19:57912057:TA:T | donor_loss | 0.9100 |
| 19:57912059:C:CA | donor_loss | 0.9100 |
| 19:57912059:C:T | donor_loss | 0.9100 |
| 19:57912185:CCCTG:C | acceptor_gain | 0.9100 |
| 19:57912186:CCTGC:C | acceptor_gain | 0.9100 |
| 19:57912187:CTG:C | acceptor_gain | 0.9100 |
| 19:57912051:GCAAC:G | donor_loss | 0.9000 |
| 19:57915955:C:T | acceptor_gain | 0.9000 |
| 19:57911431:C:CA | donor_gain | 0.8900 |
AlphaMissense
3826 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:57909111:A:C | F389L | 0.997 |
| 19:57909111:A:T | F389L | 0.997 |
| 19:57909113:A:G | F389L | 0.997 |
| 19:57909027:A:C | F417L | 0.995 |
| 19:57909027:A:T | F417L | 0.995 |
| 19:57909029:A:G | F417L | 0.995 |
| 19:57909084:A:C | H398Q | 0.995 |
| 19:57909084:A:T | H398Q | 0.995 |
| 19:57908691:A:C | F529L | 0.994 |
| 19:57908691:A:T | F529L | 0.994 |
| 19:57908693:A:G | F529L | 0.994 |
| 19:57908775:A:C | F501L | 0.993 |
| 19:57908775:A:T | F501L | 0.993 |
| 19:57908777:A:G | F501L | 0.993 |
| 19:57908607:A:C | F557L | 0.992 |
| 19:57908607:A:T | F557L | 0.992 |
| 19:57908609:A:G | F557L | 0.992 |
| 19:57908943:A:C | F445L | 0.991 |
| 19:57908943:A:T | F445L | 0.991 |
| 19:57908945:A:G | F445L | 0.991 |
| 19:57909086:G:C | H398D | 0.991 |
| 19:57909072:A:C | H402Q | 0.990 |
| 19:57909072:A:T | H402Q | 0.990 |
| 19:57909082:T:G | Q399P | 0.988 |
| 19:57909086:G:T | H398N | 0.988 |
| 19:57909094:A:G | L395P | 0.987 |
| 19:57909363:A:C | F305L | 0.987 |
| 19:57909363:A:T | F305L | 0.987 |
| 19:57909365:A:G | F305L | 0.987 |
| 19:57909000:G:C | H426Q | 0.986 |
dbSNP variants (sampled 300 via entrez): RS1000070826 (19:57917743 G>C), RS1000513626 (19:57917953 T>C), RS1000751349 (19:57908465 C>G), RS1001311378 (19:57917453 C>T), RS1001800470 (19:57913610 G>C), RS1001924668 (19:57908261 G>A), RS1002059149 (19:57914566 CAT>C), RS1002313672 (19:57908910 T>A,G), RS1002538655 (19:57907150 C>A), RS1002692368 (19:57912476 G>A,T), RS1004051834 (19:57911487 G>T), RS1004326513 (19:57911806 C>T), RS1004346521 (19:57906442 G>A), RS1004505010 (19:57914094 TGTCAGCTGATGCAGC>T), RS1005521042 (19:57918207 A>G)
Disease associations
OMIM: gene MIM:621276 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006427_4 | Depression in smokers | 1.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | increases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Urethane | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.